Company Filing History:
5 out of 3,539 
1 out of 547 
1 out of 1 
Years Active: 2006-2021
Title: **Ehud Goldin: Innovator in Enzymatic Treatments**
Introduction
Ehud Goldin is a prominent inventor based in Rockville, Maryland, recognized for his significant contributions to the field of medicinal chemistry. With a total of six patents, his work has the potential to impact the treatment of lysosomal storage disorders, showcasing his innovative approach to drug development.
Latest Patents
Goldin's latest patents focus on substituted pyrazolopyrimidines as glucocerebrosidase activators. The patents detail methods of manufacture, compositions containing these compounds, and their applications in treating diseases such as Gaucher disease. The compounds are characterized by a general formula, wherein specific variables R, R', and X are defined in the patent application, further establishing their utility in therapeutic contexts.
Career Highlights
Throughout his career, Goldin has worked with notable institutions, including the Government of the United States of America as represented by the Secretary of the Department of Health and Human Services and the University of Kansas. His work in these organizations reflects his dedication to advancing healthcare through innovative scientific research.
Collaborations
Goldin has collaborated with esteemed colleagues such as Juan Jose Marugan and Noel Terrence Southall. These partnerships have enhanced his research capabilities, fostering an environment where innovative ideas can thrive and lead to impactful solutions in treating complex medical conditions.
Conclusion
Ehud Goldin's inventiveness and dedication to the field of chemical treatments highlight the importance of innovation in medicine. His work, especially in developing compounds for lysosomal storage disorders, stands as a testament to the potential of scientific advancements in improving patient outcomes.